REGENXBIO Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for REGENXBIO Inc. (RGNX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-227.10-263.49-280.32127.84-111.25-94.7399.94
Depreciation & Amortization16.2217.3217.619.569.486.003.98
Stock Based Compensation38.4640.2740.7938.8131.950.000.00
Change in Working Capital5.53-10.8910.0740.228.86-5.50-7.77
Change in Accounts Receivable9.713.944.8214.12-9.900.000.00
Change in Accounts Payable-0.29-2.7918.79-2.303.870.000.00
Change in Other Working Capital-3.88-0.10-8.4729.3020.240.000.00
Other Operating Activities-6.23-0.1045.064.3643.78-13.43-8.93
Net Cash from Operating Activities-173.13-218.41-207.49218.88-54.06-107.71104.65
Investing Activities
Capital Expenditures-2.44-9.9630.72-84.1826.8711.72-13.28
Purchases of Investments-190.14-86.5618.80-322.47149.630.000.00
Sales/Maturities of Investments290.24287.4718.80175.68149.63105.28-266.08
Other Investing Activities5.780.000.000.002.290.000.00
Net Cash from Investing Activities103.45190.94-11.93-406.64122.7693.56-279.36
Financing Activities
Common Stock Issued131.076.704.55222.497.420.00189.72
Common Stock Repurchased1.19-0.42-0.280.000.000.000.00
Other Financing Activities-39.58-43.19-33.39-27.24192.790.00-0.62
Net Cash from Financing Activities92.68-34.97-28.84195.25200.218.38204.44
Summary
Net Change in Cash23.00-62.43-248.267.48268.91-5.7729.73
Cash at Beginning of Period36.5598.98347.24339.7670.8476.6146.88
Cash at End of Period59.5636.5598.98347.24339.7670.8476.61
Free Cash Flow-175.56-228.37-238.21134.70-80.93-119.4391.37
Supplemental Disclosures
Interest Paid6.567.2823.1221.640.000.000.00
Income Taxes Paid-0.07-0.1411.816.00-0.190.903.44